Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.

Standard

Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. / Serebryanskaya, Tatiyana V; Yung, Tatiana; Bogdanov, Alexey A; Shchebet, Andrei; Johnsen, Steven A.; Lyakhov, Alexander S; Ivashkevich, Ludmila S; Ibrahimava, Zhanna A; Garbuzenco, Tatiyana S; Kolesnikova, Tatiyana S; Melnova, Natalya I; Gaponik, Pavel N; Ivashkevich, Oleg A.

In: J INORG BIOCHEM, Vol. 120, 2013, p. 44-53.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Serebryanskaya, TV, Yung, T, Bogdanov, AA, Shchebet, A, Johnsen, SA, Lyakhov, AS, Ivashkevich, LS, Ibrahimava, ZA, Garbuzenco, TS, Kolesnikova, TS, Melnova, NI, Gaponik, PN & Ivashkevich, OA 2013, 'Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.', J INORG BIOCHEM, vol. 120, pp. 44-53. <http://www.ncbi.nlm.nih.gov/pubmed/23305964?dopt=Citation>

APA

Serebryanskaya, T. V., Yung, T., Bogdanov, A. A., Shchebet, A., Johnsen, S. A., Lyakhov, A. S., Ivashkevich, L. S., Ibrahimava, Z. A., Garbuzenco, T. S., Kolesnikova, T. S., Melnova, N. I., Gaponik, P. N., & Ivashkevich, O. A. (2013). Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. J INORG BIOCHEM, 120, 44-53. http://www.ncbi.nlm.nih.gov/pubmed/23305964?dopt=Citation

Vancouver

Bibtex

@article{c9afda603a01484b934ce39524b64f9b,
title = "Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.",
abstract = "Two series of tetrazole-containing platinum(II) and palladium(II) chlorido complexes, trans-[ML(2)Cl(2)] (M=Pt, Pd) and cis-[PtL(2)Cl(2)]·nH(2)O (n=0, 1), where L is 1- or 2-substituted 5-aminotetrazole, have been synthesized and thoroughly characterized. Configuration of platinum(II) complexes obtained from the reaction of 5-aminotetrazoles with K(2)PtCl(4) has been found to vary depending on the nature of tetrazole derivatives and reaction conditions. According to in vitro cytotoxic evaluation, only platinum complexes display noticeable antiproliferative effect, and their cytotoxicity depends strongly on their geometry and hydrophobicity of the carrier ligands. The most promising complexes are cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O, where 1-apt is 5-amino-1-phenyltetrazole and 2-abt is 5-amino-2-tert-butyltetrazole. In comparison with cisplatin, they show comparable cytotoxic potency against cisplatin-sensitive human cancer cell lines, cis-[Pt(2-abt)(2)Cl(2)]·H(2)O performing substantially higher activity against cisplatin-resistant cell lines. Cell cycle studies in H1299 cell line indicated that cis-[Pt(2-abt)(2)Cl(2)]·H(2)O induced apoptosis launched from G2 accumulations. The DNA interaction with cis-[Pt(1-apt)(2)Cl(2)]·H(2)O was followed by UV spectroscopy, circular dichroism, hydrodynamic and electrophoretic mobility studies. Both cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O complexes appeared to be significantly less toxic than cisplatin in mice, while only compound cis-[Pt(1-apt)(2)Cl(2)]·H(2)O displayed noticeable efficacy in vivo.",
keywords = "Animals, Humans, Male, Female, Molecular Structure, Apoptosis/drug effects, Drug Resistance, Neoplasm, Cell Cycle/drug effects, Cell Line, Tumor/drug effects, Spectrophotometry, Ultraviolet, Antineoplastic Agents/chemical synthesis/*chemistry/*pharmacology, Benzothiazoles/chemistry, Circular Dichroism, Cisplatin/*analogs & derivatives/pharmacology, DNA/chemistry, Drug Screening Assays, Antitumor/methods, Isomerism, Organoplatinum Compounds/chemical synthesis/*chemistry/*pharmacology, Palladium/*chemistry, Tetrazoles/chemistry, Animals, Humans, Male, Female, Molecular Structure, Apoptosis/drug effects, Drug Resistance, Neoplasm, Cell Cycle/drug effects, Cell Line, Tumor/drug effects, Spectrophotometry, Ultraviolet, Antineoplastic Agents/chemical synthesis/*chemistry/*pharmacology, Benzothiazoles/chemistry, Circular Dichroism, Cisplatin/*analogs & derivatives/pharmacology, DNA/chemistry, Drug Screening Assays, Antitumor/methods, Isomerism, Organoplatinum Compounds/chemical synthesis/*chemistry/*pharmacology, Palladium/*chemistry, Tetrazoles/chemistry",
author = "Serebryanskaya, {Tatiyana V} and Tatiana Yung and Bogdanov, {Alexey A} and Andrei Shchebet and Johnsen, {Steven A.} and Lyakhov, {Alexander S} and Ivashkevich, {Ludmila S} and Ibrahimava, {Zhanna A} and Garbuzenco, {Tatiyana S} and Kolesnikova, {Tatiyana S} and Melnova, {Natalya I} and Gaponik, {Pavel N} and Ivashkevich, {Oleg A}",
year = "2013",
language = "English",
volume = "120",
pages = "44--53",
journal = "J INORG BIOCHEM",
issn = "0162-0134",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.

AU - Serebryanskaya, Tatiyana V

AU - Yung, Tatiana

AU - Bogdanov, Alexey A

AU - Shchebet, Andrei

AU - Johnsen, Steven A.

AU - Lyakhov, Alexander S

AU - Ivashkevich, Ludmila S

AU - Ibrahimava, Zhanna A

AU - Garbuzenco, Tatiyana S

AU - Kolesnikova, Tatiyana S

AU - Melnova, Natalya I

AU - Gaponik, Pavel N

AU - Ivashkevich, Oleg A

PY - 2013

Y1 - 2013

N2 - Two series of tetrazole-containing platinum(II) and palladium(II) chlorido complexes, trans-[ML(2)Cl(2)] (M=Pt, Pd) and cis-[PtL(2)Cl(2)]·nH(2)O (n=0, 1), where L is 1- or 2-substituted 5-aminotetrazole, have been synthesized and thoroughly characterized. Configuration of platinum(II) complexes obtained from the reaction of 5-aminotetrazoles with K(2)PtCl(4) has been found to vary depending on the nature of tetrazole derivatives and reaction conditions. According to in vitro cytotoxic evaluation, only platinum complexes display noticeable antiproliferative effect, and their cytotoxicity depends strongly on their geometry and hydrophobicity of the carrier ligands. The most promising complexes are cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O, where 1-apt is 5-amino-1-phenyltetrazole and 2-abt is 5-amino-2-tert-butyltetrazole. In comparison with cisplatin, they show comparable cytotoxic potency against cisplatin-sensitive human cancer cell lines, cis-[Pt(2-abt)(2)Cl(2)]·H(2)O performing substantially higher activity against cisplatin-resistant cell lines. Cell cycle studies in H1299 cell line indicated that cis-[Pt(2-abt)(2)Cl(2)]·H(2)O induced apoptosis launched from G2 accumulations. The DNA interaction with cis-[Pt(1-apt)(2)Cl(2)]·H(2)O was followed by UV spectroscopy, circular dichroism, hydrodynamic and electrophoretic mobility studies. Both cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O complexes appeared to be significantly less toxic than cisplatin in mice, while only compound cis-[Pt(1-apt)(2)Cl(2)]·H(2)O displayed noticeable efficacy in vivo.

AB - Two series of tetrazole-containing platinum(II) and palladium(II) chlorido complexes, trans-[ML(2)Cl(2)] (M=Pt, Pd) and cis-[PtL(2)Cl(2)]·nH(2)O (n=0, 1), where L is 1- or 2-substituted 5-aminotetrazole, have been synthesized and thoroughly characterized. Configuration of platinum(II) complexes obtained from the reaction of 5-aminotetrazoles with K(2)PtCl(4) has been found to vary depending on the nature of tetrazole derivatives and reaction conditions. According to in vitro cytotoxic evaluation, only platinum complexes display noticeable antiproliferative effect, and their cytotoxicity depends strongly on their geometry and hydrophobicity of the carrier ligands. The most promising complexes are cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O, where 1-apt is 5-amino-1-phenyltetrazole and 2-abt is 5-amino-2-tert-butyltetrazole. In comparison with cisplatin, they show comparable cytotoxic potency against cisplatin-sensitive human cancer cell lines, cis-[Pt(2-abt)(2)Cl(2)]·H(2)O performing substantially higher activity against cisplatin-resistant cell lines. Cell cycle studies in H1299 cell line indicated that cis-[Pt(2-abt)(2)Cl(2)]·H(2)O induced apoptosis launched from G2 accumulations. The DNA interaction with cis-[Pt(1-apt)(2)Cl(2)]·H(2)O was followed by UV spectroscopy, circular dichroism, hydrodynamic and electrophoretic mobility studies. Both cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O complexes appeared to be significantly less toxic than cisplatin in mice, while only compound cis-[Pt(1-apt)(2)Cl(2)]·H(2)O displayed noticeable efficacy in vivo.

KW - Animals

KW - Humans

KW - Male

KW - Female

KW - Molecular Structure

KW - Apoptosis/drug effects

KW - Drug Resistance, Neoplasm

KW - Cell Cycle/drug effects

KW - Cell Line, Tumor/drug effects

KW - Spectrophotometry, Ultraviolet

KW - Antineoplastic Agents/chemical synthesis/chemistry/pharmacology

KW - Benzothiazoles/chemistry

KW - Circular Dichroism

KW - Cisplatin/analogs & derivatives/pharmacology

KW - DNA/chemistry

KW - Drug Screening Assays, Antitumor/methods

KW - Isomerism

KW - Organoplatinum Compounds/chemical synthesis/chemistry/pharmacology

KW - Palladium/chemistry

KW - Tetrazoles/chemistry

KW - Animals

KW - Humans

KW - Male

KW - Female

KW - Molecular Structure

KW - Apoptosis/drug effects

KW - Drug Resistance, Neoplasm

KW - Cell Cycle/drug effects

KW - Cell Line, Tumor/drug effects

KW - Spectrophotometry, Ultraviolet

KW - Antineoplastic Agents/chemical synthesis/chemistry/pharmacology

KW - Benzothiazoles/chemistry

KW - Circular Dichroism

KW - Cisplatin/analogs & derivatives/pharmacology

KW - DNA/chemistry

KW - Drug Screening Assays, Antitumor/methods

KW - Isomerism

KW - Organoplatinum Compounds/chemical synthesis/chemistry/pharmacology

KW - Palladium/chemistry

KW - Tetrazoles/chemistry

M3 - SCORING: Journal article

VL - 120

SP - 44

EP - 53

JO - J INORG BIOCHEM

JF - J INORG BIOCHEM

SN - 0162-0134

ER -